8/26/2025CorrectSequence's CS-101: A Breakthru Base-Editing Therapy Cures First...

8/26/2025Pregene Secures Orphan Drug Status for Innovative Dual-Target CAR-T Th...

8/26/2025Simcere's Daridorexant Phase III Data Published and Approved in China

8/26/2025Akeso's Dual Phase III Victories Highlight Expansion of Non-Oncology T...

8/26/2025Arnatar Debuts with FDA Designations for Alagille Syndrome Candidate A...

8/26/2025Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...

8/25/2025Vivace Therapeutics Secures FDA Orphan Drug Designation for VT3989 in ...

8/25/2025Anye Pharma Completes Series A Financing to Advance Neurological Drug ...

8/25/2025BeOne Nets Up to $950M in Royalty Deal for Amgen’s Lung Cancer Drug

8/25/2025HemaCell Receives FDA IND Approval for Megakaryocyte Therapy

8/25/2025Vibrant Secures Series A Financing to Advance Computational I/O Therap...

8/25/2025Minova Secures Over ¥100M in Series B Financing Led by IDG Capital

8/23/2025IxCell Secures New Financing to Advance Cell Therapy Programs

8/23/2025Recent Executive Moves

8/22/2025Kintor's KX-826 Tincture Nabs Triumph in Phase II Male AGA Trial

8/22/2025CARsgen's Satri-cel Becomes First CAR-T Therapy for Solid Tumors to Re...

8/22/2025NMPA Approves Domestic Hexavalent Rotavirus Vaccine for Children

8/22/2025Xuanzhu's Dexitinib Gains Approval for ALK-Positive Advanced NSCLC in ...

8/22/2025Innovent Advances Immuno-Oncology with IBI3026 CTA Acceptance

8/22/2025NMPA Approves AZ/Daiichi Sankyo's Datopotamab Deruxtecan

8/22/2025LongBio Advances with Hong Kong IPO Amidst Promising Clinical Pipeline

8/22/2025Bao Pharma Advances with Hong Kong IPO amid Promising Pipeline

8/22/2025InxMed Secures Over $34M in Series C Financing to Advance Oncology Pip...

8/22/2025Premier Li Visits BeOne, Signaling China's Strategic Push for Biotech ...

8/21/2025China Drafts Guidance on Single-Arm Trials to Support Oncology Drug Ap...

8/21/2025China Proposes Conflict-of-Interest Declarations for Drug Clinical Tri...

8/21/2025Henlius Biotech Expands Oncology Portfolio with Strategic Licensing Ag...

8/21/2025Nicox Targets U.S. and China Filings After Second Phase III Win for NC...

8/21/2025Novartis' Vanrafia (atrasentan) Gains Regulatory Nod in China as Secon...

8/21/2025Zelgen Secures FDA IND Approval for Novel Trispecific Cancer Therapy

Page:18/803 Total number of articles:24074: [First][<<] [16] [17] [18] [19] [20] [>>] [End]